Related Experiment Video
Updated: Apr 15, 2026
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
The future of trials in surgical oncology
Peter Naredi1, Michael P La Quaglia2
1Department of Surgery, Sahlgrenska University Hospital and Sahlgrenska Academy, University of Gothenberg, 41345 Gothenburg, Sweden.
Abstract:
Patients with cancer generally have better outcomes when treated as part of a clinical trial compared with patients not enrolled in a clinical trial. Unfortunately, surgical participation in, and leadership of such studies, is limited. This lack of clinical investigation is adversely affecting progress in cancer surgery research and, ultimately, hinders the treatment of patients. Some of the reasons for poor surgical participation in clinical research include: limitations on funding provision; inadequate training of junior surgeons in clinical trials methodology; and inadequate support of surgical faculty members as clinical investigators. Despite these shortcomings, numerous successful surgical studies have helped to change concepts, and improve patient care in certain clinical areas. Finally, a number of possible solutions are proposed, which might improve surgical involvement in clinical trials and result in more, and better-designed and executed clinical trials in this important area of research.
Insights
Cancer patients benefit from clinical trials, but surgical participation is limited. Improving surgeon training and funding can enhance cancer surgery research and patient outcomes.
Area of Science:
- Oncology
- Surgical Research
- Clinical Trials
Background:
- Patients with cancer often experience better outcomes when enrolled in clinical trials.
- Surgical participation and leadership in cancer clinical trials are notably limited.
- This underrepresentation hinders advancements in cancer surgery research and patient treatment.
Purpose of the Study:
- To investigate the reasons behind limited surgical participation in cancer clinical trials.
- To propose solutions for enhancing surgical involvement in clinical research.
- To improve the design and execution of cancer surgery clinical trials.
Main Methods:
- The study reviews existing literature and identifies barriers to surgical participation in clinical trials.
- It analyzes factors such as funding, training, and institutional support.
- Successful surgical studies are examined to understand facilitators of participation.
Main Results:
- Key barriers include insufficient funding, inadequate training in clinical trial methodologies for junior surgeons, and limited support for faculty.
- Despite challenges, successful surgical trials have demonstrably improved patient care and altered clinical concepts.
- Proposed solutions aim to bolster surgical engagement in clinical research.
Conclusions:
- Enhancing surgical involvement in clinical trials is crucial for advancing cancer surgery research.
- Addressing barriers related to funding, training, and support is essential.
- Implementing proposed solutions can lead to more and better-designed clinical trials, ultimately benefiting cancer patients.
Related Concept Videos
01:16Clinical Trials
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
02:56Treatment Resistant Cancers
02:56Treatment Resistent Cancers